Rationing of Drugs for Rare Diseases

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.24, Iss.4, 2006-01, pp. : 315-316

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Are some orphan drugs for rare diseases too expensive? A study of purchase versus compounding costs

By Simoens Steven

Drugs & Therapy Perspectives, Vol. 27, Iss. 10, 2011-10 ,pp. : 24-26

Adis International

Access to resources Recommend Favorite

South Korea's regulatory authority has amended data requirements for the designation of orphan drugs for rare and life-threatening diseases

Inpharma, Vol. 1, Iss. 1423, 2004-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

South Korea's regulatory authority has amended data requirements for the designation of orphan drugs for rare and life-threatening diseases

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 446, 2004-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Orphan Drugs for Rare Diseases: Is it Time to Revisit Their Special Market Access Status?

By Simoens Steven

Drugs, Vol. 72, Iss. 11, 2012-07 ,pp. : 1437-1443

Adis International

Access to resources Recommend Favorite

AMPK As A Target in Rare Diseases

Current Drug Targets, Vol. 17, Iss. 8, 2016-06 ,pp. : 921-931

Bentham Science Publishers

Access to resources Recommend Favorite